Verve Therapeutics
Emily Donlon is the associate director, IT applications at Verve Therapeutics. She has worked in IT, within the biotechnology industry for 15 years. Prior to joining Verve, she was the director of IT at Casebia Therapeutics. Emily received her B.A. in english literature from Wheaton College and her M.S. in IT management from Brandeis University.
This person is not in any teams
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.